Forbion raises $2.6B, largest fundraise to date, boosting European biotech VC

Forbion, a European VC firm, closed a $2.6 billion fund, its largest ever and one of the region's biggest in recent years. This signals sustained investor appetite for biotech despite broader market volatility. The raise may bolster early-stage European life sciences funding, though deployment pace and returns remain uncertain.